High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins

This publication has 44 references indexed in Scilit:

• The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
  Trends in Cardiovascular Medicine, 2001
• Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid–protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
  Journal of Clinical Investigation, 1999
• A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet
  Nature Medicine, 1998
• Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a)
  Proceedings of the National Academy of Sciences, 1998
• Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and Younger
  JAMA, 1996
• Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells
  Atherosclerosis, 1996
• Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
  The American Journal of Cardiology, 1996
• Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
  Journal of Clinical Investigation, 1995
• Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.
  Journal of Clinical Investigation, 1991
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
  Nature, 1987